摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-amino-5-chloro-8H-indeno[1,2-c]thiophen-8-one | 473437-49-9

中文名称
——
中文别名
——
英文名称
1-amino-5-chloro-8H-indeno[1,2-c]thiophen-8-one
英文别名
3-amino-7-chloroindeno[1,2-c]thiophen-4-one
1-amino-5-chloro-8H-indeno[1,2-c]thiophen-8-one化学式
CAS
473437-49-9
化学式
C11H6ClNOS
mdl
——
分子量
235.694
InChiKey
VBXISNIKCIZGBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    71.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-amino-5-chloro-8H-indeno[1,2-c]thiophen-8-one 在 N-(8-oxo-8H-indeno[1,2-c]thiophen-1-yl)acetamide 、 乙酸酐 作用下, 以75%的产率得到N-(5-chloro-8-oxo-8H-indeno[1,2-c]thiophen-1-yl)acetamide
    参考文献:
    名称:
    Effects of Conformational Restriction of 2-Amino-3-benzoylthiophenes on A1 Adenosine Receptor Modulation
    摘要:
    2-Amino-3-benzoylthiophenes (2A3BTs) have been widely reported to act as allosteric enhancers (A Es) at the A(1) adenosine receptor (A(1)AR). Herein we describe the synthesis of a series of 1-aminoindeno[1,2-c]thiophen-8-ones and a series of (2-aminoindeno[2,1-b]thiophen-3-yl)(phenyl)methanones as conformationally rigid analogues of the 2A3BTs. These compounds were screened using a functional assay of A(1)AR-mediated phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK 1/2) in intact Chinese hamster ovary (CHO) cells to identify both potential agonistic effects as well as the ability to allosterically modulate the activity of the orthosteric agonist, N-6-(R-phenylisopropyl)adenosine (R-PIA). All of the 1-aminoindeno[1,2-c]thiophen-8-ones (14a-c and 17a-f) proved either to be inactive or behaved as antagonists in the functional assay. However, the (2-aminoindeno[2, 1-b]thiophen-3-yl)(phenyl)methanones with para-chloro substitution (compounds 25b, 25d, and 25f) did significantly augment the R-PIA response, indicating a positive allosteric effect.
    DOI:
    10.1021/jm1008538
  • 作为产物:
    描述:
    2-(2-carboxybenzamido)-4-(3-chlorophenyl)thiophene-3-carboxylic acid草酰氯N,N-二甲基甲酰胺 、 aluminum (III) chloride 、 一水合肼 作用下, 以 二氯甲烷1,4-二氧六环 为溶剂, 反应 4.0h, 以55%的产率得到1-amino-5-chloro-8H-indeno[1,2-c]thiophen-8-one
    参考文献:
    名称:
    Effects of Conformational Restriction of 2-Amino-3-benzoylthiophenes on A1 Adenosine Receptor Modulation
    摘要:
    2-Amino-3-benzoylthiophenes (2A3BTs) have been widely reported to act as allosteric enhancers (A Es) at the A(1) adenosine receptor (A(1)AR). Herein we describe the synthesis of a series of 1-aminoindeno[1,2-c]thiophen-8-ones and a series of (2-aminoindeno[2,1-b]thiophen-3-yl)(phenyl)methanones as conformationally rigid analogues of the 2A3BTs. These compounds were screened using a functional assay of A(1)AR-mediated phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK 1/2) in intact Chinese hamster ovary (CHO) cells to identify both potential agonistic effects as well as the ability to allosterically modulate the activity of the orthosteric agonist, N-6-(R-phenylisopropyl)adenosine (R-PIA). All of the 1-aminoindeno[1,2-c]thiophen-8-ones (14a-c and 17a-f) proved either to be inactive or behaved as antagonists in the functional assay. However, the (2-aminoindeno[2, 1-b]thiophen-3-yl)(phenyl)methanones with para-chloro substitution (compounds 25b, 25d, and 25f) did significantly augment the R-PIA response, indicating a positive allosteric effect.
    DOI:
    10.1021/jm1008538
点击查看最新优质反应信息

文献信息

  • Pharmaceutically active compounds and methods of use
    申请人:——
    公开号:US20030073733A1
    公开(公告)日:2003-04-17
    New fused thiophene compounds are provided and methods of using those compounds for a variety of therapeutic indications. Compounds of the invention are particularly useful for treatment of neuropathic pain.
    提供了新的融合噻吩化合物,并提供了使用这些化合物治疗各种治疗适应症的方法。该发明的化合物特别适用于治疗神经病性疼痛。
  • PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
    申请人:King Pharmaceuticals, Inc.
    公开号:EP1383463A2
    公开(公告)日:2004-01-28
  • EP1383463A4
    申请人:——
    公开号:EP1383463A4
    公开(公告)日:2009-03-25
  • FUSED THIOPHENE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF CHRONIC PAIN
    申请人:King Pharmaceuticals, Inc.
    公开号:EP1383463B1
    公开(公告)日:2011-04-27
  • US7101905B2
    申请人:——
    公开号:US7101905B2
    公开(公告)日:2006-09-05
查看更多